| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 05/02/2006 | CA2445428C Process for the preparation of 4-amino-1-hydroxybutylidene-1, 1-biphosphonic acid |
| 04/27/2006 | WO2006043839A1 Nitrobenzindoles and their use in cancer therapy |
| 04/27/2006 | WO2006043757A1 Thermosensitive and biocompatible amphiphilic cyclic phosphazene trimer and preparation method thereof |
| 04/27/2006 | WO2006043110A1 Light emitting complex salts |
| 04/27/2006 | WO2006024862A3 Desymmetrisation process for the preparation of chiral phosphines |
| 04/27/2006 | WO2006012046A3 Preparation of aminophosphines |
| 04/27/2006 | WO2005121086A3 Piperidinyl prostaglandin analogs as ocular hypotensive agents |
| 04/27/2006 | WO2005114197A3 Activity-based probes for protein tyrosine phosphatases |
| 04/27/2006 | WO2005054871A3 Analysis of mass spectral data in the quiet zones |
| 04/27/2006 | WO2004105773A3 Use of s1p |
| 04/27/2006 | US20060089514 Anhydrous flouride salts and reagents and methods for their production |
| 04/27/2006 | US20060089513 Fluorine compound and fluorinating agent comprising the compound |
| 04/27/2006 | US20060089508 Process for the preparation of highly purified, dialkyl phosphinic acids |
| 04/27/2006 | US20060089506 Reacting a diol with bromine in the presence of a trivalent bismuth compound and a base of an alkali metal carbonate or alkali metal hydroxide, to form carbonyl compounds |
| 04/27/2006 | US20060089469 Hydroxy diphosphines and their use in catalysis |
| 04/27/2006 | US20060089383 Substituted piperidine compounds and methods of their use |
| 04/27/2006 | US20060089354 ligands for receptor localization studies; for inhibiting binding of vanilloid ligand to a capsaicin receptor; Phosphoric acid dibenzyl ester 4-(4-tert-butyl-phenylamino)-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-2-ylmethyl ester; to treat neuropathic pain, itch, urinary incontinence, cough, obesity |
| 04/27/2006 | US20060089336 4-Dedimethylamino tetracycline compounds |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/27/2006 | US20060089333 Hyperproliferative disorders; lyophilisates; shelf life; pharmacokinetics |
| 04/27/2006 | US20060089332 prodrugs include enantiomorphs, stereoisomers and isomers as well as solvates and metabolites of 1,2-bis(methylsulfonyl)-2-(2-chloroethyl)hydrazine-carboxylic acid 1-(3-phosphonoxy-4-nitrophenyl)ethyl ester, used as antitumor or anticarcinogenic agents |
| 04/27/2006 | US20060088582 Phosphatidyl oligo glycerins and structural analogs |
| 04/27/2006 | DE102004052040A1 Liganden zur asymmetrischen Hydroformylierung Ligands for asymmetric hydroformylation |
| 04/27/2006 | DE102004051456A1 Neue Bisphosphankatalysatoren New Bisphosphankatalysatoren |
| 04/27/2006 | CA2584702A1 Nitrobenzindoles and their use in cancer therapy |
| 04/27/2006 | CA2584537A1 Formulations containing alkylphosphocholines using novel negative charge carriers |
| 04/27/2006 | CA2584410A1 Light emitting complex salts |
| 04/26/2006 | EP1650217A1 Novel optically active phosphorus-chiral diphosphetanes, intermediates of the same, and transition metal complexes containing the diphosphetanes as the ligand |
| 04/26/2006 | EP1650216A1 Process for producing optically active dimer of phosphorus heterocycle |
| 04/26/2006 | EP1650215A1 Process for preparing lysophoshatidylcholine |
| 04/26/2006 | EP1650192A1 Quinolone derivative or salt thereof |
| 04/26/2006 | EP1648908A1 Process for preparing acylphosphanes and derivatives thereof |
| 04/26/2006 | EP1648900A2 Phosphorus-containing macrocycles |
| 04/26/2006 | EP1648883A2 Lanthanide complexes preparation and uses thereof |
| 04/26/2006 | EP1648242A1 Emulsions |
| 04/26/2006 | EP1648240A1 Aqueous lecithin dispersions |
| 04/26/2006 | EP1465852A4 Synthesis of combretastatin a-2 prodrugs |
| 04/26/2006 | EP1094055B1 Novel vinylbenzene derivatives |
| 04/26/2006 | CN1764668A Phosphonooxy quinazoline derivatives and their pharmaceutical use |
| 04/26/2006 | CN1764667A Teritiary phosphines and preparation method thereof |
| 04/26/2006 | CN1764666A Phosphonium and preparation method thereof |
| 04/26/2006 | CN1763057A Nucleotide analog compound |
| 04/26/2006 | CN1763056A Nucleotide analog compound |
| 04/26/2006 | CN1763055A N-(2-benzimidazolemethyl) imidodimethyl phosphonic acid synthesis method |
| 04/25/2006 | US7034177 Process of making phosphordiamidite compounds |
| 04/25/2006 | US7034176 Aminopropylphosphinic acids |
| 04/25/2006 | US7034168 Process for the production of phospholipids |
| 04/25/2006 | US7034093 Coordination catalyst consisting of phosphine liagnd and cobalt, nickel, iron or palladium metal |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/25/2006 | US7034014 Phosphonate compounds |
| 04/25/2006 | US7034006 Use of lipid conjugates in the treatment of disease |
| 04/20/2006 | WO2006041975A1 Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and method of making them |
| 04/20/2006 | WO2006040023A1 Method for purifying chelate ligands containing phosphorus |
| 04/20/2006 | WO2006012052A3 Amidinate ligand containing chemical vapor deposition precursors |
| 04/20/2006 | US20060084832 reacting 1,3-butadiene with a compound containing an active hydrogen atom such as water, alkanol or a hydroxy-aromatic in the presence of a group VIII metal catalyst and phosphabicycloalkyl ring ligand |
| 04/20/2006 | US20060084734 Dialkylphosphinic salts, their use, and a process for their preparation |
| 04/20/2006 | US20060084690 Isoxazole derivatives |
| 04/20/2006 | US20060084648 Ethynyl derivatives as factor xa inhibitors |
| 04/20/2006 | DE102004050910A1 Composition containing phospholipid, sterol and negative charge carrier, useful e.g. for treating parasitic diseases and tumors, acts by stimulating leucopoiesis |
| 04/20/2006 | CA2583114A1 Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and method of making them |
| 04/20/2006 | CA2582589A1 Lipopolymer conjugates |
| 04/19/2006 | EP1646616A2 Combretastatin derivatives with cytotoxic action |
| 04/19/2006 | EP1646599A1 Minimization of ligand degradation products, or reversion of same to useful phosphine ligands |
| 04/19/2006 | EP1646284A2 Azole derivatives and methods for making the same |
| 04/19/2006 | EP1227101B1 Process for the preparation of condensed phosphoric acid esters |
| 04/19/2006 | EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | CN1761675A Polymerisation catalysts |
| 04/19/2006 | CN1760199A Method for preparing L-ascorbic acid-2-phosphate ester and salt |
| 04/19/2006 | CN1760198A New type spirocyclic phosphic ester, preparation method and application in asymmetric addition reaction |
| 04/19/2006 | CN1252077C Flame retardants which contain phosphorus, and flame-retardant thermoplastic molding compositions |
| 04/19/2006 | CN1252076C Method for preparing phosphate |
| 04/19/2006 | CN1252029C Water soluble tri-substituted 1, 2-dioxetane compounds having increased storage stability, synthetic processes and intermediates |
| 04/19/2006 | CN1251800C Cationic catalyst system |
| 04/19/2006 | CN1251679C Nucleotide analog composition and synthesis method |
| 04/19/2006 | CN1251598C Process for making a downstream processable ammonium glyphosate paste |
| 04/18/2006 | US7030256 Metal-ligand complexes has a dianionic ligand chelating to the metal; non-metallocene group 4 complexes as polymerization catalyst for preparing isotactic polypropylene, or copolymers of ethylene/olefin; high molecular weight polypropylene with a high melting point |
| 04/18/2006 | US7030200 nickel, palladium, iron or cobalt complexes with neutral ligands that contain one or both of the imino (C=N) or phosphinidine (C=P) or (P-C=N) groups; polymerization of ethylene for example |
| 04/18/2006 | US7030150 Benzimidazole compounds and antiviral uses thereof |
| 04/18/2006 | US7030123 Indole derivatives with vascular damaging activity |
| 04/18/2006 | US7030103 Such as ((benzylsulfonylamino)methyl)-phosphonic acid mono-(4-nitrophenyl)ester sodium salt; for treating bacterial antibiotic resistance |
| 04/18/2006 | US7030063 Cyclohexenonquinolinoyl-derivatives as herbicidal agents |
| 04/18/2006 | US7030042 Systems and methods for forming tantalum oxide layers and tantalum precursor compounds |
| 04/18/2006 | CA2241852C Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 04/13/2006 | WO2006039527A1 Macrocyclic sh2 domain binding inhibitors |
| 04/13/2006 | WO2006039440A1 Poly(arylene ether) composition |
| 04/13/2006 | WO2006038870A1 New process for the preparation of alkyl phosphinic acids |
| 04/13/2006 | WO2006038741A1 Method for producing thioether compound |
| 04/13/2006 | WO2006038719A1 Phosphonic acid derivative and therapeutic agent for disease in which high phosphate level in blood participates |
| 04/13/2006 | WO2006028958A3 Pyridyl inhibitors of hedgehog signalling |
| 04/13/2006 | WO2006024770A3 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 04/13/2006 | WO2006008250A3 Oxime derivatives and the use therof as latent acids |
| 04/13/2006 | WO2002038576A1 ARYL PHOSPHATE DERIVATIVES OF d4T |
| 04/13/2006 | US20060079712 Oxidation of N-(phosphonomethyl)iminodiacetic acid; crystallization |
| 04/13/2006 | US20060079703 Process for preparing lysophosphatidylcholine |
| 04/13/2006 | US20060079699 Intermediate compounds and methods for synthesizing chemiluminescent dioxetane substrates |
| 04/13/2006 | US20060079695 Antibacterial oxalidinones |
| 04/13/2006 | US20060079691 Ionic liquids having [n(cf3)2]-anions |
| 04/13/2006 | US20060079679 Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them |
| 04/13/2006 | US20060079487 including pyridinium-1-yl, quinolinium-1-yl, and related compounds; parasitic infections, for example against trypanosomes; inhibiting the enzyme farnesyl diphosphate synthase |